A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate.

"CONFLICT OF INTEREST The authors declare no conflict of interest."

"The authors are grateful for the support of the National Council for Scientific and Technological Development of Brazil (CNPq), the Science without Borders Program (grant 200307/2015‐0), the Coordination for the Improvement of Higher Education Personnel (CAPES; grant Nr. 077/2012) and the University of Salzburg's Priority Program Allergy‐Cancer‐BioNano Research Centre. ESS was the recipient of a scholarship from the Research's Foundation of the State of Bahia (Fapesb, grant BOL0449/2015) and currently is supported by a post doc fellowship from  the CAPES Foundation (grant, 88887.357066/2019‐00). EMMAB is supported by a scholarship from CAPES. NMAN and LGCP are recipients of research fellowships from CNPq."